Patients with MEN1 having gastrinomas were identified in the Dutch MEN1 database from 1990 to 2014 based on fasting serum gastrin (FSG) levels and/or pathology. The gene discussed is MEN1; the disease is gastrin-producing neuroendocrine tumor.